RESEARCH TRIANGLE PARK, NC, Nov. 5, 2020 — Pappas Capital, a leading venture capital firm focused on advancing life sciences, today announced that its portfolio company, VelosBio Inc. (“VelosBio” or the...
Liquidia Technologies has added an additional investor, PPD, Inc., to its Series C financing
News | 04. 20. 2010
Liquidia Technologies
RESEARCH TRIANGLE PARK, N.C., April 20, 2010 –(EON: Enhanced Online News)– Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, announced today that it has added an additional investor, PPD, Inc., to its Series C financing. The final addition of PPD brings the total funding for this round to $25 million. The initial Series C closing was announced in January 2010.
